Table 2.
Most common Gram-positive pathogens isolated in microbiologically evaluable patients
| Pathogen | Value (%) for treatment group |
||
|---|---|---|---|
| TD-1792 (n = 63) | Vancomycin (n = 63) | Total (n = 126) | |
| From infection site | 63 (100) | 61 (97) | 124 (98) |
| Gram-positive pathogens only | 61 (97) | 57 (93) | 118 (95) |
| Any Staphylococcus aureusa | 52 (83) | 54 (89) | 106 (85) |
| MRSA | 38 (60) | 36 (59) | 74 (60) |
| MSSA | 12 (19) | 18 (30) | 30 (24) |
| Streptococcus agalactiae | 3 (5) | 3 (5) | 6 (5) |
| Streptococcus mitis | 1 (2) | 3 (5) | 4 (3) |
| Streptococcus pyogenes | 0 | 2 (3) | 2 (2) |
| Any Streptococcus | 9 (14) | 10 (16) | 19 (15) |
| Any Enterococcus | 2 (3) | 2 (3) | 4 (3) |
| From blood | 3 (5) | 5 (8) | 8 (6) |
| Staphylococcus aureus | 3 (5) | 4 (7) | 7 (6) |
| Streptococcus intermedius | 0 | 1 (2) | 1 (<1) |
a
Susceptibility to oxacillin was not determined in two isolates.